Patient Preference and Long-term Outcomes in Persistent Spinal Pain Syndrome: A Prospective Study Comparing Spinal Cord Stimulation to Intrathecal Drug Delivery.

NCT07091123 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Persistent Spinal Pain Syndrome

Interventions

DEVICE: Pain pump
DRUG: Bupivacain 0.625%/Fentanyl 2mcg/ml
DEVICE: Spinal Cord Stimulator (SCS)

Sponsor

University Hospitals Cleveland Medical Center